[(4-methoxyphenyl)(2-oxo-2-piperidin-1-ylethyl)amino]acetic acid
- $126 - $716.1
- Product name: [(4-methoxyphenyl)(2-oxo-2-piperidin-1-ylethyl)amino]acetic acid
- CAS: 1142205-63-7
- MF: C16H22N2O4
- MW: 306.36
- EINECS:
- MDL Number:MFCD12027668
- Synonyms:[(4-methoxyphenyl)(2-oxo-2-piperidin-1-ylethyl)amino]acetic acid;N-(4-methoxyphenyl)-N-(2-oxo-2-(piperidin-1-yl)ethyl)glycine;Glycine, N-(4-methoxyphenyl)-N-[2-oxo-2-(1-piperidinyl)ethyl]-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0081622
- Product description[(4-METHOXYPHENYL)(2-OXO-2-PIPERIDIN-1-YLETHYL)-AMINO]ACETIC ACID 95.00%
- Packaging500MG
- Price$716.1
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11347372
- Product description2-((4-Methoxyphenyl)(2-oxo-2-(piperidin-1-yl)ethyl)amino)aceticacid 97%
- Packaging5g
- Price$446
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number039164
- Product description[(4-Methoxyphenyl)(2-oxo-2-piperidin-1-ylethyl)-amino]acetic acid
- Packaging500mg
- Price$126
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0081622 | [(4-METHOXYPHENYL)(2-OXO-2-PIPERIDIN-1-YLETHYL)-AMINO]ACETIC ACID 95.00% | 500MG | $716.1 | 2021-12-16 | Buy |
Crysdot | CD11347372 | 2-((4-Methoxyphenyl)(2-oxo-2-(piperidin-1-yl)ethyl)amino)aceticacid 97% | 5g | $446 | 2021-12-16 | Buy |
Matrix Scientific | 039164 | [(4-Methoxyphenyl)(2-oxo-2-piperidin-1-ylethyl)-amino]acetic acid | 500mg | $126 | 2021-12-16 | Buy |
Properties
Boiling point :549.0±45.0 °C(Predicted)
Density :1.243±0.06 g/cm3(Predicted)
pka :2.00±0.10(Predicted)
Density :1.243±0.06 g/cm3(Predicted)
pka :2.00±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|